Select Asset Management & Trust’s AbbVie ABBV Stock Holding History

Select Asset Management & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Hold	6,500	–	–	0.47%	22
2026 Q1	$1.41M	Hold	6,500	–	–	0.44%	23
2025 Q4	$1.49M	Hold	6,500	–	–	0.46%	24
2025 Q3	$1.5M	Hold	6,500	–	–	0.46%	26
2025 Q2	$1.21M	Buy	6,500 +500	+8%	+$92.9K	0.41%	27
2025 Q1	$1.26M	Hold	6,000	–	–	0.5%	24
2024 Q4	$1.07M	Buy	+6,000	New	+$1.1M	0.41%	27

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Select Asset Management & Trust's ABBV Position: Q2 2026 in Review

Select Asset Management & Trust held its AbbVie (ABBV) position steady in Q2 2026 at 6,500 shares worth $1.64M. The position accounts for 0.47% of the portfolio, ranked #22.

Select Asset Management & Trust first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Select Asset Management & Trust held 6,500 shares of AbbVie worth $1.64M as of Q2 2026.
Select Asset Management & Trust left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.47% of Select Asset Management & Trust's portfolio in Q2 2026, its #22 holding.
Select Asset Management & Trust first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Select Asset Management & Trust's 13F filing for Q2 2026, filed 11 Aug 2026.